PDC Therapeutics

PDC Therapeutics

Biotechnology start-up advancing clinically-valiated platform technology Sagitta® for polymer-drug conjugates.

Biotechnology ResearchLausanne, Switzerland
Industry
Biotechnology Research
Company size
2–10 employees
On LinkedIn
6 people
Followers
816
Founded
2020
Headquarters
Lausanne, Switzerland

About PDC Therapeutics

Biotechnology start-up advancing clinically-valiated platform technology Sagitta® for polymer-drug conjugates.

Specialties

biotechnology

Similar companies

Public company page on MeetWho · meetwho.app